Tagmokitug
Tagmokitug (CHS-114) is a fully human IgG1 antibody that targets CCR8. Tagmokitug has the potential for the study of head and neck squamous cell carcinoma (HNSCC). The isotype control for Tagmokitug can refer to Human IgG1 lambda2, Isotype Control.
Product Specifications
CAS Number
3024486-14-1
Product Name Alternative
CHS-114; SRF-114
UNSPSC
12352203
Target
CCR
Related Pathways
GPCR/G Protein; Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
[Tagmokitug]
References & Citations
[1]N. Rajasekaran, et al. CHS-114: A Cytolytic Anti-CCR8 Antibody that Depletes Tumor-infiltrating Regulatory T Cells as a Treatment for Head and Neck Squamous Cell Carcinoma. Volume 118, Issue 5e89April 01, 2024.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
